investment.com

Acrivon Therapeutics, Inc. — insider transactions

10 transactions on record · ACRV · CIK 1781174

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
10
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
6
Bought, 3m
$0
Sold, 3m
$39.4K
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$31K
2026-08-25
Director share, 12m
30.0%
of transactions where role is stated
Current run
10 sells
consecutive same-direction transactions
Net 3m flow
-$39.4K
purchases minus sales
Total on record
10

Transactions

10 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-072026-10-052Miller MaryChief Legal OfficerOpen market sale294$1.99$585.1filing
2026-08-272026-08-252Masson KristinaDirector, EVP - Business OperationsOpen market sale14,036$2.21$31Kfiling
2026-08-202026-08-182Miller MaryChief Legal OfficerOpen market sale185$2.01$371.8filing
2026-08-202026-08-182Peterson KatharineChief Accounting OfficerOpen market sale101$2.01$203filing
2026-08-202026-08-182Masson KristinaDirector, EVP - Business OperationsOpen market sale1,229$2.01$2.5Kfiling
2026-08-202026-08-182Masson KristinaDirector, EVP - Business OperationsOpen market sale484$2.01$972.8filing
2026-08-202026-08-182Devroe EricChief Operating OfficerOpen market sale604$2.01$1.2Kfiling
2026-08-202026-08-182Gamelin ErickChief Development OfficerOpen market sale400$2.01$804filing
2026-08-062026-08-042Levy Adam D.Chief Financial OfficerOpen market sale1,142$1.57$1.8Kfiling
2026-07-232026-07-212Miller MaryChief Legal OfficerOpen market sale573$1.76$1Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR

Privacy controls

We use essential cookies for sign-in, security and saved features. Recent-search history and performance analytics are optional and off until you choose.

Read our privacy policy
Acrivon Therapeutics, Inc. insider transactions — 10 filings on record — investment.com